$MNOV
MEDICINOVA INC

2013 Q1 Form 10-K Financial Statement

#000119312513132600 Filed on March 28, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 2011 Q4
Revenue $3.000K $802.6K $0.00
YoY Change -98.43%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $800.0K $0.00
YoY Change -100.0%
Gross Profit Margin 0.0% 99.68%
Selling, General & Admin $1.720M $6.730M $2.060M
YoY Change -21.46% -19.11% -0.48%
% of Gross Profit 841.25%
Research & Development $500.0K $4.500M $1.440M
YoY Change -73.38% -42.19% -36.84%
% of Gross Profit 562.5%
Depreciation & Amortization $33.57K $69.53K $10.00K
YoY Change 275.3% 66.06% -50.0%
% of Gross Profit 8.69%
Operating Expenses $2.421M $11.75M $3.503M
YoY Change -40.43% -27.07% -19.47%
Operating Profit -$2.417M -$10.95M -$3.503M
YoY Change -37.59% -32.05% -19.47%
Interest Expense $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -101.61%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$2.420M -$10.95M -$3.490M
YoY Change -37.42% -38.21% -29.92%
Income Tax -$1.245K $11.14K $10.00K
% Of Pretax Income
Net Earnings -$2.419M -$10.96M -$3.503M
YoY Change -37.45% -38.19% -29.8%
Net Earnings / Revenue -80633.33% -1365.76%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$0.14 -$663.4K -$217.9K
COMMON SHARES
Basic Shares Outstanding 18.24M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q1 2012 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.000M $4.000M $15.10M
YoY Change -72.73% -73.51% -46.64%
Cash & Equivalents $3.029M $4.000M $15.09M
Short-Term Investments
Other Short-Term Assets $700.0K $400.0K $600.0K
YoY Change -12.5% -33.33% -98.01%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.713M $4.400M $15.71M
YoY Change -68.54% -71.97% -73.06%
LONG-TERM ASSETS
Property, Plant & Equipment $69.91K $100.0K $29.43K
YoY Change -70.58%
Goodwill $9.600M $9.600M
YoY Change
Intangibles
YoY Change
Long-Term Investments $700.0K $700.0K $700.0K
YoY Change 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $15.13M $15.20M $15.08M
YoY Change 0.22% 0.66% 3.29%
TOTAL ASSETS
Total Short-Term Assets $3.713M $4.400M $15.71M
Total Long-Term Assets $15.13M $15.20M $15.08M
Total Assets $18.85M $19.60M $30.79M
YoY Change -29.94% -36.36% -57.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $269.9K $500.0K $718.9K
YoY Change -10.05% -28.57% -34.65%
Accrued Expenses $432.0K $500.0K $1.516M
YoY Change -76.0% -76.19% 1.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $948.2K $1.000M $3.697M
YoY Change -64.88% -72.97% -89.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.700M $1.700M $1.600M
YoY Change 6.25% 6.25%
Total Long-Term Liabilities $1.700M $1.700M $1.600M
YoY Change 6.25% 6.25% -83.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $948.2K $1.000M $3.697M
Total Long-Term Liabilities $1.700M $1.700M $1.600M
Total Liabilities $4.598M $4.700M $7.290M
YoY Change -27.01% -35.62% -84.88%
SHAREHOLDERS EQUITY
Retained Earnings -$298.7M -$285.3M
YoY Change
Common Stock $18.26K $16.13K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.124M $1.190M
YoY Change
Treasury Stock Shares 0.000 shares 39.60K shares
Shareholders Equity $14.25M $14.90M $23.50M
YoY Change
Total Liabilities & Shareholders Equity $18.85M $19.60M $30.79M
YoY Change -29.94% -36.36% -57.77%

Cashflow Statement

Concept 2013 Q1 2012 2011 Q4
OPERATING ACTIVITIES
Net Income -$2.419M -$10.96M -$3.503M
YoY Change -37.45% -38.19% -29.8%
Depreciation, Depletion And Amortization $33.57K $69.53K $10.00K
YoY Change 275.3% 66.06% -50.0%
Cash From Operating Activities -$2.622M -$11.86M -$950.0K
YoY Change -23.5% -10.85% -73.76%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $83.38K -$10.00K
YoY Change -100.0% 1270.22% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$680.0K $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $4.800K -$763.4K -$10.00K
YoY Change -100.7% 12445.24% -101.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.629M -$1.545M
YoY Change -84.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.636M 1.545M 7.310M
YoY Change 5764.8% 892.71% 10342.86%
NET CHANGE
Cash From Operating Activities -2.622M -11.86M -950.0K
Cash From Investing Activities 4.800K -763.4K -10.00K
Cash From Financing Activities 1.636M 1.545M 7.310M
Net Change In Cash -981.5K -11.08M 6.350M
YoY Change -75.99% -15.78% -318.21%
FREE CASH FLOW
Cash From Operating Activities -$2.622M -$11.86M -$950.0K
Capital Expenditures $0.00 $83.38K -$10.00K
Free Cash Flow -$2.622M -$11.95M -$940.0K
YoY Change -23.67% -10.27% -73.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2000Q3 mnov Share Based Compensation Arrangement By Share Based Payment Award Period After Termination Date During Which Vested Options Can Be Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodAfterTerminationDateDuringWhichVestedOptionsCanBeExercisable
P90D
CY2012Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
680000
CY2010Q2 mnov Warrants Expiration Date
WarrantsExpirationDate
10-May-17
CY2010Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.1287 pure
CY2010Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2010Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
198020 shares
CY2010Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q2 dei Entity Public Float
EntityPublicFloat
22014000
CY2000Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.00
CY2000Q3 mnov Share Based Compensation Arrangement By Share Based Payment Award Options Annual Vesting Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAnnualVestingPercentage
0.25 pure
CY2010Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
6.06
CY2011Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
6.80
CY2005Q1 mnov Common Stock Outstanding Percentage
CommonStockOutstandingPercentage
0.03 pure
CY2005Q1 mnov Increase In Number Of Shares Available For Issuance Under Incentive Plan
IncreaseInNumberOfSharesAvailableForIssuanceUnderIncentivePlan
100000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
130000 shares
CY2012Q3 mnov Class Of Warrant Or Right Fair Value
ClassOfWarrantOrRightFairValue
100000
CY2012Q3 mnov Class Of Warrants Or Rights Exercise Price Of Warrants Or Rights
ClassOfWarrantsOrRightsExercisePriceOfWarrantsOrRights
1.88
CY2012Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30 pure
CY2012Q1 mnov Equity Method Investment Third Party Percentage
EquityMethodInvestmentThirdPartyPercentage
0.70 pure
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18244502 shares
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
40013474
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
24704360
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28252204
CY2012Q3 mnov Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2012Q3 mnov Other Asset Amortization Period
OtherAssetAmortizationPeriod
P1Y
CY2000Q4 us-gaap Stockholders Equity
StockholdersEquity
4848675
CY2001Q4 us-gaap Stockholders Equity
StockholdersEquity
8053941
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
1122465
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
4569882
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
7669122
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
135707779
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
100980908
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
66608201
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
48044532
CY2011Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.56
CY2011Q1 mnov Consists Of Each Firm Commitment Underwritten Public Offering Unit
ConsistsOfEachFirmCommitmentUnderwrittenPublicOfferingUnit
One share of common stock, and a warrant to purchase one share of common stock.
CY2011Q4 us-gaap Liabilities
Liabilities
7289784
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
718882
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
79215000
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
863510
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
988000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-285272483
CY2011Q1 mnov Firm Commitment Underwritten Public Offering Gross Amount
FirmCommitmentUnderwrittenPublicOfferingGrossAmount
8250000
CY2011Q1 mnov Firm Commitment Underwritten Public Offering Price
FirmCommitmentUnderwrittenPublicOfferingPrice
3.00
CY2011Q1 mnov Number Of Units In Firm Commitment Underwritten Public Offering
NumberOfUnitsInFirmCommitmentUnderwrittenPublicOffering
2750000 shares
CY2011Q1 mnov Number Of Units Over Allotted
NumberOfUnitsOverAllotted
412500 shares
CY2011Q1 mnov Number Of Units Underwriter Exercised
NumberOfUnitsUnderwriterExercised
50666 shares
CY2011Q1 mnov Waived Off Penalty Payment Amount
WaivedOffPenaltyPaymentAmount
437000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
614540
CY2011Q4 us-gaap Goodwill
Goodwill
9600241
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
955360
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
87833000
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
89789000
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7124000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
23497546
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
599087
CY2011Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
221380
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
39600 shares
CY2011Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2011Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16088015 shares
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
395000
CY2011Q4 us-gaap Assets
Assets
30787330
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.52
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30787330
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
172648
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1189705
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15093124
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16127615 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-56845
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1515815
CY2011Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
561332
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3697294
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3092671 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
16128
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1636490
CY2011Q4 us-gaap Assets Current
AssetsCurrent
15707664
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
89789000
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
925935
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29425
CY2011Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
650000
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
309998251
CY2011Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
2067000
CY2011Q4 mnov Accrued Expense
AccruedExpense
1515815
CY2011Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
411592
CY2012Q4 us-gaap Goodwill
Goodwill
9600241
CY2012Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
750775
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
92226000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94182000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2089963 shares
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7145000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
14879992
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1000000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
228124
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
228397
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4186 shares
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.32
CY2012Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17403125 shares
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
570000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
77039
CY2012Q4 us-gaap Liabilities
Liabilities
4688049
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
491853
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
83783000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3163
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
862000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296233797
CY2012Q4 us-gaap Assets
Assets
19568041
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.92
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19568041
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
170386
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1131086
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4010530
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17407311 shares
CY2012Q4 us-gaap Common Stockholders Equity
CommonStockholdersEquity
14879922
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-67957
CY2012Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7173997 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
314652
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
351992
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1037792
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3328981 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
17407
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694257
CY2012Q4 us-gaap Assets Current
AssetsCurrent
4422122
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
94182000
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
77039
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
672301
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78474
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
667204
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
312293225
CY2012Q4 mnov Working Capital Net
WorkingCapitalNet
3400000
CY2012Q4 mnov Tax Credit Carryforward Limitation
TaxCreditCarryforwardLimitation
1000000
CY2012Q4 mnov Annual Limitation Of Net Operating Loss Carryforwards
AnnualLimitationOfNetOperatingLossCarryforwards
7300000
CY2012Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
1822000
CY2012Q4 mnov Accrued Expense
AccruedExpense
314652
CY2012Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2012Q4 mnov Maturity Period Of Investment In Cash Equivalents Securities
MaturityPeriodOfInvestmentInCashEquivalentsSecurities
Three months or less
CY2005Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2005Q1 mnov Termination Period
TerminationPeriod
P10Y
CY2007Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
300000 shares
CY2008Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1000000 shares
CY2000Q3 mnov Share Based Compensation Arrangement By Share Based Payment Award Period Of Time Options Become Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfTimeOptionsBecomeExercisable
P10Y
CY2000Q3 mnov Share Based Compensation Arrangement By Share Based Payment Award Options Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPeriod
P36M
CY2010Q2 mnov Debt Instrument Agreement Date
DebtInstrumentAgreementDate
May 2010
CY2011Q4 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
2500000
CY2011Q4 mnov Upfront Payment Related To Research And Development Services
UpfrontPaymentRelatedToResearchAndDevelopmentServices
2500000
CY2012Q3 mnov Class Of Warrant Or Rights Exercisable Period From Date Of Issuance
ClassOfWarrantOrRightsExercisablePeriodFromDateOfIssuance
P15M
CY2011Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
7700000
CY2011Q1 mnov Exercise Period Of Warrants
ExercisePeriodOfWarrants
P5Y
CY2009 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
81967
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
406357
CY2009 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35170
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-20368890
CY2009 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2371636
CY2009 mnov Adjustments To Additional Paid In Capital Fair Value Of Redemption Feature Of Purchase Of Business Combination
AdjustmentsToAdditionalPaidInCapitalFairValueOfRedemptionFeatureOfPurchaseOfBusinessCombination
9513042
CY2009 mnov Average Value Of Shares Issued Under Employee Stock Purchase Plan
AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan
2.21
CY2010 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
859208
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
1804780
CY2010 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
37460
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166599
CY2010 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9212
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-20187308
CY2010 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000935
CY2010 mnov Average Value Of Shares Issued Under Employee Stock Purchase Plan
AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan
6.56
CY2001 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1794734
CY2002 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6931476
CY2003 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6209130
CY2005 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
55445
CY2005 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5557773
CY2005 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15188
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-25692135
CY2005 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
19689
CY2005 mnov Amortization Of Deferred Employee Stock Based Compensation
AmortizationOfDeferredEmployeeStockBasedCompensation
311282
CY2005 mnov Conversion Of Redeemable Convertible Preferred Stock Into Common Stock
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock
43502765
CY2005 mnov Issuance Costs For Registration
IssuanceCostsForRegistration
165476
CY2005 mnov Issuance Of Common Stock
IssuanceOfCommonStock
38.80
CY2005 mnov Stock Based Compensation Option Vesting Acceleration And Reissuance Of Options
StockBasedCompensationOptionVestingAccelerationAndReissuanceOfOptions
127875
CY2005 mnov Treasury Stock Dollar Amount Per Share
TreasuryStockDollarAmountPerShare
11.10
CY2006 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1400 shares
CY2006 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1382425
CY2006 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2006 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34017
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-35689611
CY2006 mnov Amortization Of Deferred Employee Stock Based Compensation
AmortizationOfDeferredEmployeeStockBasedCompensation
2090182
CY2006 mnov Cashless Warrant Exercises Shares
CashlessWarrantExercisesShares
260000 shares
CY2006 mnov Option Exercised Dollar Amount Per Share
OptionExercisedDollarAmountPerShare
10.00
CY2006 mnov Warrant Exercised Dollar Amount Per Share
WarrantExercisedDollarAmountPerShare
1.00
CY2006 mnov Warrant Exercises
WarrantExercises
275000
CY2006 mnov Warrant Exercises Shares
WarrantExercisesShares
275000 shares
CY2007 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
33782
CY2007 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10639600
CY2007 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-82261
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-48903244
CY2007 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
12.00
CY2007 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3939416
CY2007 mnov Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
6 M
CY2007 mnov Average Value Of Shares Issued Under Employee Stock Purchase Plan
AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan
6.72
CY2007 mnov Cashless Warrant Exercises Shares
CashlessWarrantExercisesShares
650047 shares
CY2007 mnov Common Stock Fair Market Value Percentage
CommonStockFairMarketValuePercentage
0.85 pure
CY2007 mnov Percentage Of Employee Compensation For Purchase Of Common Stock Under Espp
PercentageOfEmployeeCompensationForPurchaseOfCommonStockUnderEspp
Cannot exceed 15%
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-16108434
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.016 pure
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9715100
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41869
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
1372748
CY2011 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
17
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
76473
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-8230
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
80000
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13308652
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6085
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
12010
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8230
CY2011 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
81292
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2500000
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055 pure
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1951951
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6085
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13159080
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
250333
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8323715
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-164563
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1431000 shares
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76263
CY2011 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
62316
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1143
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1143
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7784719
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155657
CY2011 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
529114
CY2011 us-gaap Operating Expenses
OperatingExpenses
16108434
CY2011 us-gaap Repayments Of Debt
RepaymentsOfDebt
15000000
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.371 pure
CY2011 us-gaap Depreciation
Depreciation
41869
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17722503
CY2011 us-gaap Interest Paid
InterestPaid
1088926
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14813156 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8291357 shares
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-17734076
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11573
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17734076
CY2011 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17735219
CY2011 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
2.50
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1372748
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5355854
CY2011 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
97929
CY2011 us-gaap Interest Expense
InterestExpense
1595093
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.25
CY2011 mnov Issuance Of Warrants
IssuanceOfWarrants
2882258
CY2011 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.050 pure
CY2011 mnov Amortization Of Premium Discount On Investment Securities Convertible Notes And Debt Discount And Issuance Costs
AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts
-752124
CY2011 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
-656196
CY2011 mnov Issuance Of Common Stock Net Of Issuance Costs
IssuanceOfCommonStockNetOfIssuanceCosts
48049
CY2011 mnov Proceeds From Conversion Of Convertible Notes
ProceedsFromConversionOfConvertibleNotes
76473
CY2011 mnov Restricted Assets Cash Unrestricted Upon Conversion Of Convertible Notes
RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes
76473
CY2000 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-201325
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000
CY2000 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.00
CY2004 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34069916
CY2004 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48272603
CY2004 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
78756
CY2004 mnov Amortization Of Deferred Employee Stock Based Compensation
AmortizationOfDeferredEmployeeStockBasedCompensation
224579
CY2008 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
86726
CY2008 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
101722
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-21924829
CY2008 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3172712
CY2008 mnov Average Value Of Shares Issued Under Employee Stock Purchase Plan
AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan
2.33
CY2012 dei Trading Symbol
TradingSymbol
MNOV
CY2012 dei Entity Registrant Name
EntityRegistrantName
MEDICINOVA INC
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001226616
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-10945356
CY2012 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Deferred Revenue and Revenue Recognition</i></b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In October 2011, we entered into an agreement with Kissei Pharmaceutical Co., Ltd., or Kissei, to perform research and development services relating to MN-221 in exchange for a non-refundable upfront payment of $2.5&#xA0;million. Under the terms of the agreement we are responsible for all costs to be incurred in the performance of these services. Certain of these research and development services were completed in 2012 and the remaining services are expected to be delivered and completed after 2013. We assessed the deliverables in accordance with the authoritative guidance and concluded the existence of one deliverable, research and development services. As such, we are recognizing as revenue the $2.5 million payment as the research and development services are performed. The amount received from Kissei, net of the amount recorded as revenue, is included on the balance sheet as deferred revenue and will be recognized as revenue as we perform the remaining services. Revenue recorded in 2012 was $0.8 million. No revenue was recorded in 2011.</font></p> </div>
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1486603
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
100000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-823
CY2012 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
800000
CY2012 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
680000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69528
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
709650
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.01
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.57
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60000 shares
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-58619
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11864438
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-763378
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
10951
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11112
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
58619
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
29605
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.30
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058 pure
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1348873
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83378
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11082594
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-370964
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6734844
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1900000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-266927
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
750000 shares
CY2012 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
137730
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
24791
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11112
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5013092
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
35414 shares
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1545222
CY2012 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
286762
CY2012 us-gaap Operating Expenses
OperatingExpenses
11747936
CY2012 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
453690 shares
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2012 us-gaap Revenues
Revenues
802580
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.401 pure
CY2012 us-gaap Depreciation
Depreciation
33507
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10950170
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16522929 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8657667 shares
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-10961314
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11144
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10961314
CY2012 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
276655 shares
CY2012 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10972426
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates under different assumptions or conditions.</font></p> </div>
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
709650
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2829785
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11460
CY2012 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
96415
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.33
CY2012 mnov Employee Stock Purchase Plan Number Of Shares Available For Issuance
EmployeeStockPurchasePlanNumberOfSharesAvailableForIssuance
249578 shares
CY2012 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.007 pure
CY2012 mnov Cumulative Stock Ownership Change Period
CumulativeStockOwnershipChangePeriod
P3Y
CY2012 mnov Amortization Of Deferred Revenue
AmortizationOfDeferredRevenue
-802580
CY2012 mnov Increase In Ownership Percentage
IncreaseInOwnershipPercentage
0.50 pure
CY2012 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
-776508
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
377205766
us-gaap Operating Income Loss
OperatingIncomeLoss
-278209637
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
132665225
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
680000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2014052
us-gaap Share Based Compensation
ShareBasedCompensation
50390931
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-5982
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
256845
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1164868
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-209712471
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4901434
us-gaap Income Taxes Paid
IncomeTaxesPaid
69601
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
389230
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2500000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
14670000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2360968
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4010530
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
131983
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
112257368
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
310664
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
19145183
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1735212
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-67957
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
167054655
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218624435
us-gaap Cost Of Revenue
CostOfRevenue
1258421
us-gaap Operating Expenses
OperatingExpenses
280570444
us-gaap Repayments Of Debt
RepaymentsOfDebt
15000000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
5000000
us-gaap Revenues
Revenues
2360807
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-264794714
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
43515677
us-gaap Interest Paid
InterestPaid
2487343
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
377918240
us-gaap Net Income Loss
NetIncomeLoss
-264870675
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
98445
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75961
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-296233797
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-296301754
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
85572825
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1196091
us-gaap Interest Expense
InterestExpense
3605818
mnov Issuance Of Warrants
IssuanceOfWarrants
2882258
mnov Number Of Licenses
NumberOfLicenses
8 Agreement
mnov Amortization Of Deferred Revenue
AmortizationOfDeferredRevenue
1697420
mnov Amortization Of Premium Discount On Investment Securities Convertible Notes And Debt Discount And Issuance Costs
AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts
1099365
mnov Deemed Dividend Resulting From Convertible Preferred Stock
DeemedDividendResultingFromConvertiblePreferredStock
31264677
mnov Impairment Charge Gain Net On Investment Securities And Ars Put
ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut
-1735212
mnov Impairment Of Sublease
ImpairmentOfSublease
35259
mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
545034
mnov Proceeds From Ars Loan
ProceedsFromArsLoan
17605485
mnov Proceeds From Conversion Of Convertible Notes
ProceedsFromConversionOfConvertibleNotes
1881253
mnov Repayments Of Ars Loan
RepaymentsOfArsLoan
17605485
mnov Restricted Assets Cash Unrestricted Upon Conversion Of Convertible Notes
RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes
1881815
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
4976000
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-5656000
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5656000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
4064000
CY2012Q1 us-gaap Revenues
Revenues
191000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-3867000
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3867000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
2781000
CY2012Q2 us-gaap Revenues
Revenues
494000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2281000
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2281000
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
3722000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-4681000
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4681000
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
3907000
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-3894000
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3894000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
2446000
CY2012Q3 us-gaap Revenues
Revenues
84000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2379000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2379000
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2011Q4 us-gaap Operating Expenses
OperatingExpenses
3503000
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-3503000
CY2011Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3503000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
2455000
CY2012Q4 us-gaap Revenues
Revenues
34000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-2434000
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2434000

Files In Submission

Name View Source Status
0001193125-13-132600-index-headers.html Edgar Link pending
0001193125-13-132600-index.html Edgar Link pending
0001193125-13-132600.txt Edgar Link pending
0001193125-13-132600-xbrl.zip Edgar Link pending
d448827d10k.htm Edgar Link pending
d448827dex103.htm Edgar Link pending
d448827dex231.htm Edgar Link pending
d448827dex311.htm Edgar Link pending
d448827dex312.htm Edgar Link pending
d448827dex321.htm Edgar Link pending
d448827dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g448827g48u55.jpg Edgar Link pending
g448827g60d31.jpg Edgar Link pending
g448827g62i13.jpg Edgar Link pending
mnov-20121231.xml Edgar Link completed
mnov-20121231.xsd Edgar Link pending
mnov-20121231_cal.xml Edgar Link unprocessable
mnov-20121231_def.xml Edgar Link unprocessable
mnov-20121231_lab.xml Edgar Link unprocessable
mnov-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending